Jennifer Tousignant - Chief Legal Officer at Viridian Therapeutics, Inc.\DE

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Legal Officer
Issuer Symbol
VRDN on Nasdaq
All Insider Reports
All Insider Reports

Jennifer Tousignant - trading volume in the past year for Viridian Therapeutics, Inc.\DE

Holdings reported by Jennifer Tousignant for Viridian Therapeutics, Inc.\DE

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Restricted Stock Units 15,510 $484,095 $23.41 03 Mar 2026 Direct Common Stock
Common Stock 3,494 $105,029 $30.06 03 Mar 2026 Direct
Stock Option (Right to Buy) 119,300 02 Mar 2026 Direct Common Stock

Transactions reported by Jennifer Tousignant for Viridian Therapeutics, Inc.\DE

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.